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Results.  The  visual  inspection  and  the  chemical  analysis  revealed  unsuitable  packag-
ing  (mostly  lacking of  adequate  information  for  consumers),  absence of  the declared 
active  substances  and  presence  of  undeclared  active  substances.  Products  containing 












Italian  legislation  implementing  the  European  Di-




have  a  common  logo  that  is  recognizable  throughout 
the European Union. 
Over  the  last  few  years  the  Italian  Official  Medi-
cines Control Laboratory (OMCL) has been  involved 
in  the  analytical  control  of  a  growing number  of  sus-
pected samples seized by Carabinieri NAS (the Italian 
Police Force  that deals with health  related crimes) or 






In  this  paper,  the  results  of  laboratory  analysis  per-
formed on all kinds of suspicious medicines sent to the 
OMCL are  reported. A number of  food  supplements 
suspected  to  fraudulently  contain  pharmaceutical  ac-
tive ingredients such as PDE5-i or slimming substances 




MATERIALS AND METHODS 
The  samples  considered  in  this  paper  came  from 
seizures  in gyms, sexy-shops and ethno-shops or from 
custom  officers  inspections  of  container  shipment  or 
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illegal,  counterfeit,  etc.).  Depending  on  the  request 

















matograph  equipped with  a  time-of-flight mass  spec-
trometer  detector  (MS)  (Agilent  Technologies,  Fast 
HPLC Mod.  1290  Infinity  +  Q-TOF Mod.  G6520B 
with  a Dual  ESI  source).  For most  of  the  samples  a 









For quantitative  analysis  validated  liquid  chromato-
graphic methods reported in the marketing authoriza-




procedure was stressed  to be sure  to obtain  the com-
plete  recovery of  the active  ingredient. For medicines 
copying  the  original  products  (mainly  those  against 
men  impotence)  infra-red  spectroscopy  and  thermal 




magnetic  resonance  (NMR) was used  for  a definitive 
identification of the active substance. 
The product marketing status (product illegally mar-
keted,  prescription-only  medicine,  doping  substance 















list  [5],  mainly  anabolic  steroids.  Among  them  there 
was nandrolone decanoate  that  is  listed  in  the  Italian 




analysed  medicines  declared  to  contain  sibutramine, 






Table 1  reports  the  observations  deriving  from  the 
visual  inspection  of  packaging  and  the  outcomes  of 




















Details on screening method in the analysis of illegal/counter-
feit medicines and food supplements.
Solvent extraction: methanol
LC parameters
Column: C18, 2.1x50 mm, 1.8  µm
Gradient elution: from 95/5v/v H2O/CH3CN + 0.1% formic acid to 
5/95v/v H2O/CH3CN +0.1% formic acid in 15 min; 
Flow rate = 0.4 mL/min;
Injection volume = 1 mL;
T column = 35°C
MS parameters
Source: Dual ESI in positive ion conditions
T gas(N2) = 300°C
Drying gas = 10 L/min
Nebulizer = 40 psig
Fragmentor = 100V
MS-MS Targeted mode
Collision Offset Voltage = 30V



















terfeits,  the  information on  the origin of  the product 
could be false.





belled  active  ingredient  and  in  few  cases  a  different, 





identification  of  different  excipients  with  respect  to 
the original branded sample (in particular for samples 
VIAGRA®-  and  CIALIS®-like)  and  in  particular  non-
pharmaceutical  excipients  (such  as  gypsum)  were 
found.  In  many  cases  undeclared  lactose,  that  can 

























marketed  in  the  country  [11].  Table 1  evidences  that 
most  of  food  supplements  analysed were not  notified 
to the Ministry of Health (86%) and 28% of them con-
tained undisclosed pharmaceutical substances.
The  packaging  examination  confirmed  the  same 
quality problems observed on medicines. All the actives 
found  in  food  supplements  and  natural  herbal  rem-






Quality evaluation (packaging visual inspection and analytical results) performed on medicinal samples and food supplements 
purchased by citizens over the Internet market and seized by Customs or seized on the illegal market in Italy from 2011 to 2013
Visual inspection % of failures in medicines
(105 samples tested)
% of failures in food supplements
(29 samples tested)
Outer packaging missing1 72 10
Immediate packaging missing 3 0
Immediate packaging damaged 11 14
Expiry date and/or batch number missing, illegible or 
inconsistent2
12 34
Manufacturer’s name and/or manufacturing country missing 37 55
Label not in Italian 79 24
Mistakes on label 6 14
No label at all 4 0
Illegal product3 61 86
Analytical results
Absence of the labelled active substance 7 (% of 91 samples) NA(4)
OOS4 assay 35 (% on 55 samples) NA
Presence of an undeclared pharmaceutical active substances 12 (% on 91 samples) 28
Counterfeit product 29 + 3 (I/C)5 28
1 The leaflet was missing in almost all the samples.
2 The batch number and/or the expiry date on the immediate and outer packaging were inconsistent.
3 Products with no marketing authorization in Italy (for medicines) or no notification to the Italian Ministry of Health (for food supplements).
4 Out of specifications: < 90% or > 110% of the label claim.
5 Illegal/Counterfeit medicine.
NA: not applicable.

















past as a  laxative, but  later  it has been banned for  its 
suspected cancerogenic effect  [12, 13].  In  food prod-






these  analogous  clinical  trials  are  not  available,  thus 
at  the moment  it  is  impossible  to  know  their  toxicity 
and possible adverse reactions. Moreover, food supple-












last  sample  the  GHRP-2  (growth  hormone  releasing 












samples  seized  by  Italian  Police  Forces  and  customs 
authorities  or  bought  on  the  web  by  Italian  citizens, 
contain doping agents and banned substances or pre-
scription-only  drugs. Buying medicines  on-line  or  out 
of the legal supply chain is usually considered a way to 























This  study was  carried  out  in  cooperation with  the 
national taskforce IMPACT Italia. This study was sup-
ported  by  a  grant  of  the  Italian  Medicines  Agency 
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